Miochol E

Manufacturer
Bausch & Lomb Incorporated | Norvatis Pharma Stein AG | Sanofi S.p.A. | Avara Liscate Pharmaceutical Services Spa
Effective date
2023-03-17
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
9
Source
full-release
Hydrated at
2026-05-31 20:50:55

Label at a glance#

ProductMiochol E
Active ingredientACETYLCHOLINE CHLORIDE
Label structure12 sections

Indications and uses

To obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy, and other anterior segment surgery where rapid miosis may be required.

Dosage and administration

Miochol ™ -E (acetylcholine chloride intraocular solution) is instilled into the anterior chamber before or after securing one or more sutures. Instillation should be gentle and parallel to the iris face and tangential to pupil border. If there are no mechanical hindrances, the pupil starts to constrict in seconds and the peripheral iris is drawn away from the angle of the anterior chamber. Any anatomical hindranc...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Miochol™-E (acetylcholine chloride intraocular solution) is a parasympathomimetic preparation for intraocular use. It is packaged in a blister pack containing one vial and one diluent ampule. The vial contains 20 mg acetylcholine chloride and 56 mg mannitol. The accompanying ampule contains 2 mL of a modified diluent of calcium chloride dihydrate, magnesium chloride hexahydrate, potassium chloride, sodium acetate trihydrate, and sterile water for injection.

The reconstituted liquid will be a sterile isotonic solution (275–330 milliosmoles/kg) containing 20 mg acetylcholine chloride (1:100 solution) and 2.8% mannitol. The pH range is 5.0–8.2. Mannitol is used in the process of lyophilizing acetylcholine chloride, and is not considered an active ingredient.

The chemical name for acetylcholine chloride, C7H16ClNO2, is Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride and is represented by the following chemical structure:

ChemStructure
ChemStructure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Acetylcholine is a naturally occurring neurohormone which mediates nerve impulse transmission at all cholinergic sites involving somatic and autonomic nerves. After release from the nerve ending, acetylcholine is rapidly inactivated by the enzyme acetylcholinesterase by hydrolysis to acetic acid and choline.

Direct application of acetylcholine to the iris will cause rapid miosis of short duration. Topical ocular instillation of acetylcholine to the intact eye causes no discernible response as cholinesterase destroys the molecule more rapidly than it can penetrate the cornea.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

To obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy, and other anterior segment surgery where rapid miosis may be required.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Miochol-E is contraindicated in persons with a known hypersensitivity to any component of this product.

WARNINGS

WARNINGS SECTION

DO NOT GAS STERILIZE. If blister or peelable backing is damaged or broken, sterility of the enclosed vial and ampule cannot be assured. Open under aseptic conditions only.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

If miosis is to be obtained quickly with Miochol-E, anatomical hindrances to miosis, such as anterior or posterior synechiae, must be released, prior to administration of Miochol-E. During cataract surgery, use Miochol-E only after delivery of the lens.

Aqueous solutions of acetylcholine chloride are unstable. Prepare solution immediately before use. Do not use solution which is not clear and colorless. Discard any solution that has not been used.

Drug Interactions

SPL UNCLASSIFIED SECTION

Although clinical studies with acetylcholine chloride and animal studies with acetylcholine or carbachol revealed no interference, and there is no known pharmacological basis for an interaction, there have been reports that acetylcholine chloride and carbachol have been ineffective when used in patients treated with topical nonsteroidal anti-inflammatory agents.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in pediatric patients have not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Infrequent cases of corneal edema, corneal clouding, and corneal decompensation have been reported with the use of intraocular acetylcholine.

Adverse reactions have been reported rarely, which are indicative of systemic absorption. These include bradycardia, hypotension, flushing, breathing difficulties, and sweating.

To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

OVERDOSAGE

OVERDOSAGE SECTION

Atropine sulfate (0.5 to 1 mg) should be given intramuscularly or intravenously and should be readily available to counteract possible overdosage. Epinephrine (0.1 to 1 mg subcutaneously) is also of value in overcoming severe cardiovascular or bronchoconstrictor responses.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Miochol™-E (acetylcholine chloride intraocular solution) is instilled into the anterior chamber before or after securing one or more sutures.

Instillation should be gentle and parallel to the iris face and tangential to pupil border.

If there are no mechanical hindrances, the pupil starts to constrict in seconds and the peripheral iris is drawn away from the angle of the anterior chamber. Any anatomical hindrance to miosis must be released to permit the desired effect of the drug. In most cases, 0.5 to 2 mL produces satisfactory miosis. Note that the syringe filter supplied with Miochol-E has a priming volume of 0.6 mL (approximately).

In cataract surgery, use Miochol-E only after delivery of the lens.

Aqueous solutions of acetylcholine chloride are unstable. Prepare solution immediately before use. Do not use solution that is not clear and colorless. Discard any solution that has not been used.

DIRECTIONS FOR PREPARING MIOCHOL™-E:

SPL UNCLASSIFIED SECTION

STERILE UNLESS PACKAGE OPEN OR BROKEN

  1. Inspect the unopened blister, vial, and ampule to ensure that they are all intact. Peel open the blister under a sterile field. Maintain sterility of the outer containers of the vial and ampule during preparation of solution.
  2. Aseptically attach a sterile 18–20 gauge, beveled needle to the luer tip of a sterile disposable syringe with a twisting motion to assure a secure fit.
  3. Break open the ampule containing the diluent. The One Point Cut (OPC) ampule must be opened as follows: Hold the bottom part of the ampule with the thumb pointing to the colored dot. Grasp the top of the ampule with the other hand, positioning the thumb at the colored dot, and press back to break at the existing cut under the dot.
  4. Remove the needle protector and withdraw the diluent from the ampule into the syringe. Discard the ampule.
  5. Remove and discard the cap from the top of the vial.
  6. Insert the needle through the center of the vial stopper, and transfer the diluent from the syringe to the vial. Shake gently to dissolve the powder.
  7. Slowly withdraw the solution from the vial through the needle into the syringe. Discard the needle.
  8. Aseptically open the syringe filter pouch, and attach the filter onto the luer tip of the syringe with a twisting motion to assure a secure fit.
  9. Aseptically attach a sterile blunt tip irrigation cannula to the male luer of the filter prior to intraocular irrigation.

Discard the filter appropriately after use.

Do not reuse the syringe filter.

Do not aspirate and inject through the same filter.

HOW SUPPLIED

HOW SUPPLIED SECTION

Miochol™-E

(acetylcholine chloride intraocular solution)............................NDC 24208-539-20

One blister pack containing the following components:

  • Vial of 20 mg acetylcholine chloride powder for intraocular solution
  • Ampule of 2 mL diluent

One 0.2 micron sterile filter

  • Priming volume 0.6 mL (approximately)

Storage

Store at 4°C to 25°C (39°F to 77°F).

KEEP FROM FREEZING.

Keep out of reach of children.

Distributed by:

Bausch & Lomb Americas Inc.

Bridgewater, NJ 08807 USA

Manufactured by:

Avara Liscate Pharmaceutical Services S.p.A

20050 Liscate (Milan), Italy

Miochol is a trademark of Bausch & Lomb Incorporated or its affiliates.

© 2023 Bausch & Lomb Incorporated or its affiliates

Rev. 03/2023

9735301

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 24208-539-20

Miochol TM -E

(acetylcholine chloride intraocular solution)

20 mg/2 mL (10 mg/mL)

Sterile

1:100 with Electrolyte

Diluent

FOR INTRAOCULAR

USE ONLY

Rx only

Contents:

  • One Blister Pack containing:
  • -20 mg vial
  • -2 mL diluent ampule
  • One 0.2 micron sterile filter

BAUSCH + LOMB

9735202

CartonCarton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
876551acetylcholine chloride 20 MG in 2 mL Ophthalmic SolutionPSN9
876553Miochol-E 20 MG in 2 mL Ophthalmic SolutionPSN9
876553acetylcholine chloride 10 MG/ML Ophthalmic Solution [Miochol]SBD9
876551acetylcholine chloride 10 MG/ML Ophthalmic SolutionSCD9
876551acetylcholine chloride 20 MG per 2 ML (1 % ) Intraocular SolutionSY9
876553Miochol 10 MG/ML Ophthalmic SolutionSY9
876553Miochol 20 MG per 2 ML (1 % ) Intraocular SolutionSY9

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ACETYLCHOLINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9e37788c-b1bf-42ae-aac9-b60601606144Product name820260122
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
1527ac37-808d-43be-a63e-74e1258dbe46Product name920250219
bed0530e-f939-4541-956b-6928a2f6404fProduct name120241008
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name620240814
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5Product name820230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
0ec3537a-6c9b-432a-896c-b9ea8723049aProduct name920200701
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
7916de40-e296-41f0-b811-6d0df1a33e2cProduct name920180627
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name220171212
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
24208-539-20Miochol E1 in 1 BLISTER PACKKIT19

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
24208-539MIOCHOL E (ACETYLCHOLINE CHLORIDE) KIT [BAUSCH & LOMB INCORPORATED]9Current NDC, Legacy NDC, 1 package rows20230617_e701ef07-9499-4b56-931f-f4eb3eedbe24.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24208-539-20EA - Each24208-5393608d65f-fad5-479b-a666-2c82474312ae12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ACETYLCHOLINE CHLORIDEACTIVE INGREDIENTAF73293C2R4
ACETYLCHOLINEACTIVE MOIETYN9YNS0M02X4
CALCIUM CHLORIDEINACTIVE INGREDIENTM4I0D6VV5M4
MAGNESIUM CHLORIDEINACTIVE INGREDIENT02F3473H9O4
MANNITOLINACTIVE INGREDIENT3OWL53L36A4
POTASSIUM CHLORIDEINACTIVE INGREDIENT660YQ98I104
SODIUM ACETATEINACTIVE INGREDIENT4550K0SC9B4
WATERINACTIVE INGREDIENT059QF0KO0R4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
24208-53924208-539-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 276 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / NASALNAExact identifier — unii candidate
36 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10SOLUTION / IRRIGATION0.04 %w/vExact identifier — unii candidate
36 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSYRUP / ORAL43 mgExact identifier — unii candidate
64 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, SUSPENSION / INTRAMUSCULAR71 mgExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS980.4 mgExact identifier — unii candidate
130 equally ranked IID candidates
MAGNESIUM CHLORIDEMAGNESIUM CHLORIDE02F3473H9OINJECTION, SOLUTION / INTRATHECAL1 mgExact identifier — unii candidate
14 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MSOLUTION/ DROPS / OPHTHALMIC0.02 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MSOLUTION / INTRAPERITONEAL0.03 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, DELAYED RELEASE / ORAL639 mgExact identifier — unii candidate
130 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BCREAM / TOPICALNAExact identifier — unii candidate
64 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
64 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASUSPENSION / OPHTHALMIC9 mgExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION / INTRAVENOUS15400 mgExact identifier — unii candidate
130 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MINJECTION, SOLUTION / INTRATHECAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36APOWDER, FOR SUSPENSION / INTRAMUSCULAR6.75 %w/vExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS35 mgExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASUSPENSION, EXTENDED RELEASE / ORAL2464.6 mgExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS180 mgExact identifier — unii candidate
130 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, SOLUTION / SUBCUTANEOUS0.16 %w/vExact identifier — unii candidate
64 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / INTRAVENOUS4239 mgExact identifier — unii candidate
64 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSOLUTION / INTRAVENOUS20 mgExact identifier — unii candidate
64 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS141 mgExact identifier — unii candidate
64 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10INJECTION / INFILTRATION0.3 mgExact identifier — unii candidate
36 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MINJECTION, SOLUTION / INTRA-ARTERIAL11 mgExact identifier — unii candidate
32 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR300 mgExact identifier — unii candidate
130 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MSOLUTION / INTRAOCULAR24 mgExact identifier — unii candidate
32 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, SOLUTION / SUBMUCOSAL0.08 %w/vExact identifier — unii candidate
64 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSOLUTION / ORAL44 mgExact identifier — unii candidate
64 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AGUM, CHEWING / BUCCAL891 mgExact identifier — unii candidate
130 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10SOLUTION / IRRIGATION0.04 %w/vExact identifier — unii candidate
36 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / SUBCUTANEOUS19 mgExact identifier — unii candidate
64 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MINJECTION, SUSPENSION / INTRAVITREAL0.05 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS35 mgExact identifier — unii candidate
130 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MINJECTION / INTRAMUSCULAR4 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, SOLUTION / SUBMUCOSAL2.94 %w/vExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, FOR SUSPENSION / ORAL7621 mgExact identifier — unii candidate
130 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / PARENTERAL250 mgExact identifier — unii candidate
64 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, FOR SUSPENSION / ORAL7621 mgExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION, CONCENTRATE / INTRAVENOUS220 mgExact identifier — unii candidate
130 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MSOLUTION / OPHTHALMIC1 mgExact identifier — unii candidate
32 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ACAPSULE / ORAL1562 mgExact identifier — unii candidate
130 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10SOLUTION/ DROPS / OPHTHALMIC0.14 %w/vExact identifier — unii candidate
36 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii candidate
130 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BCREAM / TOPICALNAExact identifier — unii candidate
64 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MCONCENTRATE / ORAL0.08 mg/1mlExact identifier — unii candidate
32 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AGRANULE / ORAL1328 mgExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, SUSPENSION / INTRAVENOUS2.5 %w/vExact identifier — unii candidate
130 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MINJECTABLE, LIPOSOMAL / INTRAVENOUS0.03 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION / ORAL869 mgExact identifier — unii candidate
130 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10INJECTION, SOLUTION / INTRAVENOUS330 mgExact identifier — unii candidate
36 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION / SUBCUTANEOUS4.54 %w/vExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, SOLUTION / SUBCUTANEOUS99 mgExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, CHEWABLE / ORAL3726 mgExact identifier — unii candidate
130 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, SUSPENSION / INTRAVENOUS2.5 %w/vExact identifier — unii candidate
130 equally ranked IID candidates
POTASSIUM CHLORIDEPOTASSIUM CHLORIDE660YQ98I10POWDER / RESPIRATORY (INHALATION)0.18 mgExact identifier — unii candidate
36 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, SOLUTION / SUBCUTANEOUS0.16 %w/vExact identifier — unii candidate
64 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MSOLUTION / INTRAOCULAR24 mgExact identifier — unii candidate
32 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSOLUTION / INTRAOCULAR195 mgExact identifier — unii candidate
64 equally ranked IID candidates
CALCIUM CHLORIDECALCIUM CHLORIDEM4I0D6VV5MINJECTION, SOLUTION / INTRAVENOUS11 mgExact identifier — unii candidate
32 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, SUSPENSION / INTRAVITREAL0.39 %w/vExact identifier — unii candidate
64 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020213-001MIOCHOL-EACETYLCHOLINE CHLORIDE20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22d4dbc9d85df4…
2026-10-15 13:18:302026-09N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22c2088c7a36db…
2026-09-14 22:38:342026-08N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-2284e616aacf4f…
2026-08-18 06:07:402026-07N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-226a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-2203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-222680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-225bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-2279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-221e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-228072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-225c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-225d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-224b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-2274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-2287673890dc5c…
2021-03-12 10:30 UTC2021-03N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-225aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-228869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-223f01610625f2…
2019-09-15 20:21 UTC2019-09N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22b00525d2431f…
2019-07-19 19:46 UTC2019-07N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-226a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-221c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-229b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-223f0d92c62455…
2023-05-13 08:27 UTC2023-05N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-22053a50430f4f…
2023-01-26 05:58 UTC2023-01N020213-001MIOCHOL-E20MG/VIALFOR SOLUTION / OPHTHALMICRLD, RS1993-09-223bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Miochol EACETYLCHOLINE CHLORIDEBausch & Lomb Incorporatede701ef07-9499-4b56-931f-f4eb3eedbe242023-03-17Warnings, Adverse reactionsExact identifier
ndc (package): 24208-539-20
ndc (product): 24208-539
ndc11 (package): 24208053920
spl id: 19c42ee4-9f98-48da-85ea-52090070c2e2
spl set id: e701ef07-9499-4b56-931f-f4eb3eedbe24

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.